Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trialJohannes F.E. Mann, Katherine R. Tuttle, Peter Rossing et al.|Nature Medicine|2024Cited by 152
Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart FailureScott D. Solomon, Mikhail Kosiborod, Dalane W. Kitzman et al.|Journal of the American College of Cardiology|2024Cited by 113
Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysisJohannes F.E. Mann, Vlado Perkovic, John B. Buse et al.|Diabetes Obesity and Metabolism|2021Cited by 105
Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the <scp>LEADER</scp> randomized trialOfri Mosenzon, Stephen C. Bain, Hiddo J.L. Heerspink et al.|Diabetes Obesity and Metabolism|2020Cited by 24